Article révisé par les pairs
Titre :
  • The predictive value of HER2 in breast cancer.
Auteur : Piccart-Gebhart, Martine ; Lohrisch, C ; Di Leo, Angelo ; Larsimont, Denis
Informations sur la publication : Oncology, 61 Suppl 2, (page 73-82)
Statut de publication : Publié, 2001
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Algorithms
Antibiotics, Antineoplastic -- administration & dosage
Antibodies, Monoclonal -- administration & dosage
Antibodies, Monoclonal -- therapeutic use
Antineoplastic Agents -- therapeutic use
Antineoplastic Agents, Hormonal -- contraindications
Antineoplastic Agents, Hormonal -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- chemistry
Breast Neoplasms -- genetics
Breast Neoplasms -- mortality
Chemotherapy, Adjuvant
Clinical Trials as Topic
Disease Progression
Drug Resistance, Multiple
Drug Resistance, Neoplasm
Female
Genes, erbB-2
Humans
Neoplasm Metastasis
Neoplasm Proteins -- analysis
Neoplasm Proteins -- genetics
Predictive Value of Tests
Prospective Studies
Randomized Controlled Trials as Topic
Receptor, erbB-2 -- analysis
Receptors, Estrogen -- analysis
Retrospective Studies
Risk
Survival Analysis
Tamoxifen -- contraindications
Tamoxifen -- therapeutic use
Treatment Outcome
Tumor Markers, Biological -- analysis
Tumor Markers, Biological -- genetics
Note : Comparative Study
Journal Article
Review
Langue :
  • Anglais
Identificateurs : urn:issn:0030-2414 
info:pii/ocl1b073
info:pmid/11694791